At a glance
ClinicalIndex Comparison Record- ✓Advanced idiopathic Parkinson's disease
- ✕Other diseases which might influence compliance or participation in the study
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Long-term Health Economics Study of Intraduodenal Levodopa (Duodopa®) in Routine Care for Patients With Advanced Idiopathic Parkinson's Disease With Severe Motor Fluctuations and Hyper-/Dyskinesia
In Brief
A Phase 4 clinical trial evaluating Levodopa-carbidopa intestinal gel (LCIG), CADD-Legacy® 1400 ambulatory infusion pump, and 2 other interventions for Advanced Idiopathic Parkinson's Disease. Completed, enrolled 77 participants.
Detailed Summary
The primary objective of this study is to collect health economic data depicting the initial levels and natural progression over time of resource usage, Parkinson's disease (PD)-related costs, and health related quality of life (HRQoL) for a cohort of advanced PD patients treated with Duodopa (levodopa-carbidopa in an intestinal gel formulation), of which about one-third were Duodopa-naïve prior to the start of the study.